Polarean Secures $12.6 Million in Funding to Propel XENOVIEW™ Commercialization and Innovate Pulmonary Imaging
Polarean Imaging , a pioneering leader in advanced Magnetic Resonance Imaging (MRI) for pulmonary applications, has successfully concluded a significant $12.6 million financing round through the Alternative Investment Market (AIM) of the London Stock Exchange. The oversubscribed fundraise, co-led by strategic investors NUKEM Isotopes GmbH and Bracco S.p.A., alongside a consortium of new and existing…
